
For a marginal player which did not invest very much, the sellers have laughed all the way to the bank. Photo: Video GrabExide Life Insurance has had nothing to complain about. For a company with less than a 1 per cent market by way of new business premium, the decision to sell out completely to HDFC Life has been very lucrative. The ticket value of the deal was Rs 6,687 crore and that meant a handy 2.5x of its embedded value. The way the deal has been structured gives it stock in the fast-growing HDFC Life.
There is a bit of a background to Exide Life Insurance before it came to be owned by Rajan Raheja, a businessman with interests in cement and publishing. In 2005, it first acquired a 50 per cent stake in ING Vysya Life Insurance from GMR industries. That deal was struck at just over Rs 200 crore valuing the entity at Rs 400 crore. Other shareholders in the insurance company were the Dutch financial group, ING, investment banker Hemendra Kothari and Enam Group's Vallabh Bhansali. In early 2013, they all sold their holding to Exide for Rs 550 crore, valuing the company at Rs 1,100 crore. The new company was now called Exide Life Insurance, a subsidiary of the battery manufacturer, Exide.